# NAFTIFINE HYDROCHLORIDE
> **ANDA210038** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2020-09-22
## Drug
- **FDA Application Number:** ANDA210038
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAFTIFINE HYDROCHLORIDE
- **Generic name:** Naftifine Hydrochloride
- **Active ingredients:** NAFTIFINE HYDROCHLORIDE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **First approval:** 2020-09-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210038)
---
*AI Analytics · CC0 1.0*